enfortumab,vedolizumab
takeda,astellas,seagen
['#unite', 'biomarker', 'urothelial', 'enfortumab', 'unite study', ' vedo']
independent biomarkers predictive of outcomes with enfortumab vedotin in patients with advanced #urothelialcarcinoma: analysis of the #unite study. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology